Should Older Patients with Dementia Get the Flu Shot?
Yes, older patients with dementia should absolutely receive the annual influenza vaccine—they face substantially higher risks of hospitalization and death from influenza, and vaccination reduces these outcomes by approximately 9-10% for hospitalizations and 9% for mortality. 1, 2
Why This Population Is at Particularly High Risk
Older adults with dementia represent a uniquely vulnerable population for several converging reasons:
- Age-related vulnerability: Persons aged ≥65 years have the highest rates of serious illness and death from influenza, even though infection rates are highest in children 3
- Dementia-specific risks: People with dementia have increased susceptibility to infection-related complications and may experience meaningful declines in function and cognition after acute illnesses, including vaccine-preventable infections 4
- Institutional setting amplification: Residents of nursing homes and chronic-care facilities (where many dementia patients reside) are specifically designated as a high-priority vaccination group 1, 5
Evidence of Benefit in Dementia Populations
The most recent and highest-quality evidence comes from a 2025 Danish nationwide study of 134,002 people with dementia, which demonstrated that influenza vaccination was associated with 9-10% lower hospitalization rates and 9% lower mortality rates 2. This represents real-world effectiveness in a dementia-specific population.
Additional supporting evidence includes:
- A 2021 U.S. Veterans Health Administration study of over 123,000 patients showed vaccinated individuals had 14% lower dementia risk (HR=0.86), with those receiving ≥6 vaccines showing even greater benefit (HR=0.88) 6
- A 2026 meta-analysis identified 31% lower risk of incident dementia among vaccinated adults, with specific reductions in vascular dementia (HR=0.58) 7
- Vaccination may provide neuroprotective effects beyond infection prevention by reducing vascular injury and neuroinflammation that contribute to cognitive decline 7
Specific Vaccine Recommendations
For older adults with dementia aged ≥65 years, preferentially use one of these enhanced vaccines 8:
- High-dose inactivated influenza vaccine (HD-IIV3) - contains 60 μg HA per virus
- Recombinant influenza vaccine (RIV3) - contains 45 μg HA per virus
- Adjuvanted inactivated influenza vaccine (aIIV3) - contains MF59 adjuvant
If none of these three vaccines is available, administer any other age-appropriate influenza vaccine rather than delaying vaccination 8.
These enhanced formulations are specifically designed to overcome age-related immune decline and have demonstrated superior effectiveness in preventing influenza-associated hospitalizations in older adults 8, 9.
Addressing Common Concerns
Safety profile: Influenza vaccines have a robust safety profile in older adults. The most common adverse effects are injection-site pain, fatigue, headache, and myalgia 10. The vaccine contains noninfectious killed viruses and cannot cause influenza 3.
Guillain-Barré syndrome: Current evidence does not support an increased GBS risk with modern influenza vaccines (risk is actually lower with vaccination than with influenza infection itself: 1.03 vs 17.2 GBS admissions per million) 10. The only exception is for individuals who developed GBS within 6 weeks of a previous influenza vaccination 10.
Effectiveness concerns: While one 2025 study from Taiwan suggested less pronounced protective effects in older adults with severe dementia and multiple comorbidities 11, this contradicts the larger body of evidence and should not deter vaccination, as the potential benefits far outweigh minimal risks.
Critical Implementation Points
Vaccination coverage remains inadequate: Despite clear benefits, only 62.6% of people living with dementia receive influenza vaccination—barely higher than the general population and well below the WHO target of 75% 12. This represents a significant missed opportunity for prevention.
Timing matters: Vaccinate between October and November for optimal protection, though vaccination should continue throughout the influenza season 13. For nursing home residents specifically, avoid vaccinating before October as antibody levels can decline within months 3.
Caregiver vaccination is essential: Healthcare workers, nursing home staff, and household contacts of dementia patients should also be vaccinated to reduce transmission to this vulnerable population 1, 5. Evidence shows that vaccinating healthcare personnel is associated with decreased deaths among nursing home patients 5.
The Bottom Line
Influenza vaccination in older adults with dementia is not just about preventing the flu—it's about preventing hospitalizations, functional decline, cognitive deterioration, and death. The evidence consistently demonstrates meaningful reductions in these critical outcomes, with enhanced vaccine formulations offering additional protection for this high-risk population. Every older patient with dementia should receive annual influenza vaccination unless they have a specific contraindication (such as severe egg allergy or prior GBS within 6 weeks of vaccination) 1.